or Try an Advanced Search...

    Technical Analysis for FRES - Fresh2 Group Limited

    Grade Last Price % Change Price Change
    F 0.41 4.10% 0.02
    FRES closed up 4.1 percent on Wednesday, May 15, 2024, on 6 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 16
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical FRES trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 4.10%
    Oversold Stochastic Weakness 4.10%
    NR7 Range Contraction -2.66%
    Stochastic Reached Oversold Weakness -2.66%
    Wide Bands Range Expansion -2.66%
    Oversold Stochastic Weakness -2.66%
    Wide Bands Range Expansion -3.93%
    Older End-of-Day Signals for FRES ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 16 hours ago
    Rose Above Previous Day's High about 16 hours ago
    Up 5% about 20 hours ago
    Up 3% about 20 hours ago
    Up 2% about 20 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    FRES Chart by TradingView
    Basic chart:

    Profile

    Fresh2 Group Limited is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2023. With two certified clinical laboratories in China and one CLIA and CAP accredited clinical laboratory in the United States, Fresh2 performs a suite of cancer screening and detection tests, including CDA (Cancer Differentiation Analysis), bio-chemical, immunological, and genomics tests. The Company is entering the business-to-business e-commerce food business with the formation of its wholly-owned subsidiary Fresh2 Technology Inc and the acquisition of Fresh2 Ecommerce Inc.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Chemical E Commerce Genomics Medical Laboratory Cancer Screening Science

    Is FRES a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 22 Fresh2 Group gets Nasdaq delinquency notice
    Apr 22 Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
    Feb 14 Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
    Jan 31 Fresh2 Group announces receipt of Nasdaq deficiency notice
    Jan 31 Fresh2 Group Ltd. Announces Receipt of a Bid Deficiency Notice from Nasdaq
    Dec 15 Appointment of New Independent Director
    See more FRES news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.0
    52 Week Low 0.2999
    Average Volume 111,053
    200-Day Moving Average 1.03
    50-Day Moving Average 0.47
    20-Day Moving Average 0.46
    10-Day Moving Average 0.44
    Average True Range 0.09
    RSI (14) 44.13
    ADX 23.17
    +DI 20.78
    -DI 14.09
    Chandelier Exit (Long, 3 ATRs) 0.40
    Chandelier Exit (Short, 3 ATRs) 0.58
    Upper Bollinger Bands 0.59
    Lower Bollinger Band 0.32
    Percent B (%b) 0.31
    BandWidth 58.77
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0092
    Fundamentals Value
    Market Cap 9.63 Million
    Num Shares 23.7 Million
    EPS -7.38
    Price-to-Earnings (P/E) Ratio -0.06
    Price-to-Sales 0.46
    Price-to-Book 0.62
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.48
    Resistance 3 (R3) 0.48 0.46 0.47
    Resistance 2 (R2) 0.46 0.44 0.46 0.46
    Resistance 1 (R1) 0.43 0.43 0.42 0.43 0.46
    Pivot Point 0.41 0.41 0.41 0.41 0.41
    Support 1 (S1) 0.38 0.39 0.37 0.38 0.35
    Support 2 (S2) 0.36 0.38 0.36 0.35
    Support 3 (S3) 0.33 0.36 0.34
    Support 4 (S4) 0.33